SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway

Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice

(2020) Erhan Sahin et al.   JOURNAL OF FOOD BIOCHEMISTRY

Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro

(2020) Dan Wei et al.   LIFE SCIENCES

Berberine attenuates hepatic oxidative stress in rats with non‑alcoholic fatty liver disease via the Nrf2/ARE signalling pathway

(2019) Yuanjun Deng et al.   Experimental and Therapeutic Medicine

The Toxicity Of Metallic Nanoparticles On Liver: The Subcellular Damages, Mechanisms, And Outcomes

(2019) Ying Yao et al.   International Journal of Nanomedicine

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

(2018) Mohammad Bagherniya et al.   PHARMACOLOGICAL RESEARCH

Ginseng and obesity

(2018) Zhipeng Li et al.   Journal of Ginseng Research

Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome

(2018) Soo Lim et al.   Obesity Reviews

Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway

(2018) Li Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Role of ginsenosides in reactive oxygen species-mediated anticancer therapy

(2017) Islam Sodrul et al.   Oncotarget

Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats

(2017) Xu-Jia Chen et al.   Scientific Reports

Role of ginsenosides, the main active components of Panax ginseng , in inflammatory responses and diseases

(2017) Ji Hye Kim et al.   Journal of Ginseng Research

The potential of natural products for targeting PPAR α

(2017) Daniela Rigano et al.   Acta Pharmaceutica Sinica B

A micro-RNA expression signature for human NAFLD progression

(2016) Yan Guo et al.   JOURNAL OF GASTROENTEROLOGY

Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances

(2016) Jennie Ka Ching Lau et al.   JOURNAL OF PATHOLOGY

Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease

(2016) Hyunjin Park et al.   NUTRITION RESEARCH

Hawthorn Fruit Extract Elevates Expression of Nrf2/HO-1 and Improves Lipid Profiles in Ovariectomized Rats

(2016) Jeong-Hyun Yoo et al.   Nutrients

Microbial conversion of major ginsenosides in ginseng total saponins by Platycodon grandiflorum endophytes

(2016) Lei Cui et al.   Journal of Ginseng Research

Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis

(2016) Somaiya Mateen et al.   PLoS One

Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance

(2016) Kuen Cheh Yang et al.   Scientific Reports

Classification of glycosidases that hydrolyze the specific positions and types of sugar moieties in ginsenosides

(2015) Kyung-Chul Shin et al.   CRITICAL REVIEWS IN BIOTECHNOLOGY

A review of biotransformation and pharmacology of ginsenoside compound K

(2015) Xi-Ding Yang et al.   FITOTERAPIA

Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome

(2015) Luca Miele et al.   Internal and Emergency Medicine

Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives

(2015) Federico Salomone et al.   LIVER INTERNATIONAL

Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease

(2015) Sandra Pisonero-Vaquero et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation

(2015) Jae Yun Han et al.   Journal of Ginseng Research

Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848

(2015) Chun-Ying Liu et al.   Journal of Ginseng Research

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

(2015) Jerome Boursier et al.   PLoS Pathogens

The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism

(2015) Sílvia S. Chambel et al.   Biomed Research International

The inductive effect of ginsenoside F2 on hair growth by altering the WNT signal pathway in telogen mouse skin

(2014) Heon-Sub Shin et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line

(2014) Fayeza Md. Siraj et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Characterization of a Ginsenoside-Transforming β-glucosidase from Paenibacillus mucilaginosus and Its Application for Enhanced Production of Minor Ginsenoside F2

(2014) Chang-Hao Cui et al.   PLoS One

Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats

(2013) Ling Shen et al.   JOURNAL OF LIPID RESEARCH

Mulberry leaf polyphenol extracts reduced hepatic lipid accumulation involving regulation of adenosine monophosphate activated protein kinase and lipogenic enzymes

(2013) Cheng-Hsun Wu et al.   Journal of Functional Foods

Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells

(2012) Trang Thi Mai et al.   CANCER LETTERS

Co-transformation of Panax major ginsenosides Rb1 and Rg1 to minor ginsenosides C–K and F1 by Cladosporium cladosporioides

(2012) Lunpeng Wu et al.   JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2012) Yoshihisa Takahashi   WORLD JOURNAL OF GASTROENTEROLOGY

Inhibitory Effects of Ginsenoside Re Isolated from Ginseng Berry on Histamine and Cytokine Release in Human Mast Cells and Human Alveolar Epithelial Cells

(2012) Hye-Min Bae et al.   Journal of Ginseng Research

Anti-Cancer Effect of Ginsenoside F2against Glioblastoma Multiforme in Xenograft Model in SD Rats

(2012) Ji-Yon Shin et al.   Journal of Ginseng Research

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

(2011) Yu Li et al.   Cell Metabolism

Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

(2011) Jun-Fen Fu   WORLD JOURNAL OF GASTROENTEROLOGY

Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice

(2010) Myoung-Su Lee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anti-Obesity effects of protopanaxdiol types of Ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet

(2010) Rui Liu et al.   FITOTERAPIA

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

(2010) Rohit Kohli et al.   HEPATOLOGY

Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease

(2010) S. Kaser et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Nrf2 the rescue: Effects of the antioxidative/electrophilic response on the liver

(2010) Curtis D. Klaassen et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Pharmacology of ginsenosides: a literature review

(2010) Kar Leung et al.   Chinese Medicine

Resveratrol protects primary rat hepatocytes against oxidative stress damage:

(2008) Juan Andrés Rubiolo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY